WeChat Unveils Developer Guide for AI Ecosystem Access as US Tech Stocks Rebound

Stock News07:43

WeChat Open Class has released a guidance document for developers seeking to integrate with the WeChat AI ecosystem.

On June 8th, WeChat Open Class published the "Guidance for Developers on Accessing the WeChat AI Ecosystem." The guidance states that the WeChat Open Platform, while fully respecting developers' rights and autonomy, provides capabilities for convenient access to the WeChat AI ecosystem, allowing developers to actively authorize such integration. This involves Hong Kong-listed TENCENT (00700).

It is understood that KFC, as one of the first batch of catering enterprises to join, has taken the lead in gaining access. Subsequently, users can issue ordering commands using natural spoken language, and the system can accurately recognize the requests, intelligently match meal sets, recommend preferred stores, and simultaneously display distance and available pickup times, significantly simplifying the entire ordering and pickup process.

Meituan indicated that, as part of the initial internal testing team, it had previously collaborated with the WeChat team on joint development and testing for access. Reportedly, in the future, users will be able to invoke local life services like Meituan delivery through the WeChat Agent, enabling a more intelligent and convenient AI-powered life service experience.

On June 8th, Tongcheng Travel announced it is about to fully access the WeChat AI Agent ecosystem, becoming one of the first online travel platforms to integrate with the WeChat AI ecosystem.

Market Outlook

The three major US stock indices closed mixed, with most large-cap technology stocks advancing.

At the close of overnight US trading, the Dow Jones Industrial Average fell by 80.77 points to 50,786.01, a decline of 0.16%. The S&P 500 index gained 21.99 points to 7,405.73, up 0.3%. The Nasdaq Composite Index rose by 220.23 points to 25,929.66, an increase of 0.86%.

Most large-cap tech stocks rose, with chip and semiconductor stocks rebounding. The Philadelphia Semiconductor Index jumped 5.6%. Intel surged over 11%, and Micron Technology climbed more than 9%. Optical communication concept stocks strengthened, with Marvell Technology gaining over 9%, Applied Optoelectronics soaring more than 11%, and Astera Labs advancing over 9%.

Most popular Chinese concept stocks declined, with the Nasdaq Golden Dragon China Index dropping 0.62%.

Hong Kong's Hang Seng Index ADRs rose. On a pro-rata basis, it closed at 24,731.15 points, up 74.09 points or 0.30% from the Hong Kong market close.

The front-month WTI crude oil futures contract on the New York Mercantile Exchange increased by $0.74 to settle at $91.28 per barrel, a gain of 0.82%.

The front-month COMEX gold futures contract fell by $11.50, or 0.26%, to $4,353.8 per ounce.

Sector Focus

Hong Kong Exchanges Tech 100 Index rebalancing: Three stocks including Zhipu AI (02513) to be added, effective June 15th.

On June 8th, Hong Kong Exchanges announced that, according to the fast inclusion mechanism, Zhipu AI (02513), Biren Technology (06082), and Tianshu Zhixin (09903) will be included in the HKEX Tech 100 Index. The inclusion will be implemented after the market close on Friday, June 12th, and take effect from Monday, June 15th.

The overnight loans provided by the Hong Kong Monetary Authority to banks on Monday climbed to the highest level in three months. HK$920 million was lent through the so-called discount window, the highest since March 17th.

Rongchang Biotech (09995): The National Medical Products Administration has conditionally approved the new drug application for Telitacicept (RC18) injection for the treatment of IgA Nephropathy.

In accordance with the "Drug Administration Law of the People's Republic of China" and related regulations, upon review, Telitacicept injection meets the relevant requirements for drug registration. This conditional approval for marketing applies to reducing urinary protein in adult patients with primary Immunoglobulin A Nephropathy (IgAN) who are at risk of disease progression.

Additionally, Rongchang Biotech (09995) announced that the company has received the "Drug Registration Certificate" issued and approved by the National Medical Products Administration. The new indication for Telitacicept for Injection (code: RC18, trade name: Taiai®, approval number: Guo Yao Zhun Zi S20210008, certificate number: 2026S01909) for the treatment of Sjögren's Syndrome has been approved for marketing.

China Hongqiao (01378) receives share purchase from controlling shareholder China Hongqiao Holding.

China Hongqiao (01378) issued an announcement stating that the company's board was notified that its controlling shareholder, China Hongqiao Holding Company Limited, purchased a total of 21 million company shares from the open market on June 8, 2026, at an average price of approximately HK$26.4641 per share, equivalent to about 0.21% of the total issued shares of the company as of the date of this announcement.

China Hongqiao Holding believes the company's current share price deviates from its value. China Hongqiao Holding does not rule out further increasing its shareholding in the company at an appropriate time in the future, subject to compliance with applicable laws and regulatory provisions. The share purchase reflects China Hongqiao Holding's confidence in the future prospects and long-term development of the group.

Tencent reveals new WeChat AI ecosystem layout; Tongcheng Travel (00780) becomes first batch OTA to gain access.

Tongcheng Travel announced it is about to fully access the WeChat AI Agent ecosystem, becoming one of the first batch of online travel platforms (OTAs) to integrate with the WeChat AI ecosystem. In the future, users can propose travel needs via voice commands or text input within the WeChat AI Agent, and artificial intelligence will complete itinerary planning, enabling comparison, decision-making, and booking services for travel products.

It is reported that Tongcheng Travel's core product booking services for flights, train tickets, hotels, attraction tickets, and vacation packages will simultaneously access the WeChat AI Agent ecosystem. Furthermore, over 3,200 hotels under Tongcheng Travel's Yilong Hotel Technology and Wanda Hotels & Resorts will also fully integrate with the WeChat AI Agent.

Contel (01912) controlling interest to change hands; receives general offer at a discount of approximately 34.82%; trading resumes June 9th.

Contel (01912) announced that on May 5, 2026, the company proposed to issue approximately 271 million subscription shares to Zhuangyan Investment International Limited (the Subscriber), representing about 58.81% of the enlarged issued share capital, at a subscription price of HK$0.365 per share. This represents a discount of approximately 34.82% compared to the closing price of HK$0.560 per share on the Stock Exchange on the last trading day.

The net proceeds from the subscription are estimated to be approximately HK$98.7 million.

Stock Spotlight

Weimob (02013): Reportedly conducting internal testing on new AI product.

According to a report, Weimob is currently conducting internal testing on its AI product "Weimob Xing Shu." "Weimob Xing Shu is positioned as a full-platform AI intelligent growth engine for e-commerce. Merchants only need to use natural language dialogue to manage mainstream domestic e-commerce platforms with one click," a relevant person in charge at Weimob stated. Once the product is launched, it will become China's first AI product for vertical e-commerce scenarios that connects all mainstream e-commerce platforms and traffic portals.

According to Weimob's 2025 financial report, its annual revenue related to AI exceeded 100 million yuan for the first time. Guojin Securities noted that AI+SaaS has moved from the "proof of concept" stage into the "large-scale value realization" stage. Leading enterprises like Weimob (02013) are expected to reach an inflection point in profitability during 2026-2027, with core drivers coming from high growth in AI product revenue, the explosion of the GEO market, and the scaling effects of cost reduction and efficiency improvement.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment